PAM
ZSAN

Panagora Asset Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Panagora Asset Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-14
Closed -$5K – 2430
2017
Q4 		$5K Sell
14
-16
-53% -$8.03K ﹤0.01% 2256
2017
Q3 		$17K Sell
30
-6
-17% -$4.4K ﹤0.01% 2197
2017
Q2 		$36K Hold
36
– – ﹤0.01% 2141
2017
Q1 		$48K Hold
36
– – ﹤0.01% 2027
2016
Q4 		$20K Hold
36
– – ﹤0.01% 2225
2016
Q3 		$19K Buy
+36
New +$28.7K ﹤0.01% 2265

Other funds holding ZSAN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Panagora Asset Management's ZSAN Position: Q1 2018 in Review

Panagora Asset Management sold out of Zosano Pharma Corporation (ZSAN) in Q1 2018, closing a stake of 14 shares — an estimated $5K sold.

Panagora Asset Management first reported a position in ZSAN in Q3 2016 and held it in 6 quarters. The position peaked at $48K in Q1 2017. 32 funds tracked by Wall St. Rank hold ZSAN as of Q1 2018.

  • Panagora Asset Management reported no remaining Zosano Pharma Corporation position as of Q1 2018 after selling out during the quarter.
  • Panagora Asset Management sold 14 Zosano Pharma Corporation shares in Q1 2018, an estimated $5K.
  • Panagora Asset Management first reported a position in Zosano Pharma Corporation in Q3 2016 and held it in 6 quarters.
  • Panagora Asset Management's Zosano Pharma Corporation position peaked at $48K in Q1 2017.
  • 32 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2018.

Based on Panagora Asset Management's 13F filing for Q1 2018, filed 15 May 2018.